23 min listen
Spark Therapeutics: Gene Therapy For Inherited Retinal Disease - Jay Newman
Spark Therapeutics: Gene Therapy For Inherited Retinal Disease - Jay Newman
ratings:
Length:
39 minutes
Released:
Dec 6, 2021
Format:
Podcast episode
Description
Jay Newman, Head of U.S. Commercial at Spark Therapeutics provides a detailed overview of gene therapy for inherited retinal disease. Jay discusses the challenges associated with gaining regulatory approval and how this approval has impacted the company and the low vision community at large.
Released:
Dec 6, 2021
Format:
Podcast episode
Titles in the series (74)
Artificial Intelligence Meets Ophthalmology With DIAGNOS: Andre Larente, President of DIAGNOS, explains how artificial intelligence is impacting the field of ophthalmology, enabling for early detection of diabetic retinopathy and other blinding eye diseases. Mr. Larente further explains how his companies te... by BroadEye: An Ophthalmology Podcast